Xenical

MARCH 01, 2004

Roche (Nutley, NJ) recently announced that the FDA has approved labeling for use of the prescription weight-loss medication Xenical (orlistat) in the management of obese adolescents aged 12 to 16 years. This approval offers physicians and parents of overweight and obese adolescents a safe and effective treatment option to help manage their weight. Xenical works locally in the stomach to prevent dietary fat absorption by approximately 30%. It helps the patient lose weight as well as maintain the weight loss. For more information, visit www.xenical.com.



SHARE THIS SHARE THIS
0

Conference Coverage

Check back here regularly for live conference coverage from the American Academy of Pain Medicine and the upcoming American Pharmacists Association Meeting and Expo. 


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.